TNFRSF11B and diabetes mellitus: To control for the effects of the Fc fragment of the recombinant OPG-Fc or DMB antibody used in our studies, we used IgG as an additional control in every category of experiments in vitro, including cell death assay, Western blot analysis, and GSIS assays, as well as for the in vivo diabetes reversal studies.